Tanabe Pharma releases ALS book
By Rob Bale
Pharmaceutical company Tanabe Pharma Canada has released a book called “Letters to ALS: Our Journeys to Hope.” The book is a collection of letters from people with amyotrophic lateral sclerosis, as well as family members, clinicians, researchers and advocates. According to the company, the intent of the book is to provide insight into the reality of living with the disease. A digital edition of the book is available free via Google Play Books. In addition, a limited number of print copies will be distributed through ALS clinics and patient advocacy organizations nationally.
“While many people impacted by ALS have courageously shared their stories publicly, this book offers a unique approach, allowing individuals from across the ALS community to write letters directly to ALS itself,” said Sophy Olafson, a neurology account specialist at Tanabe. “These letters to ALS created a space where raw emotions like anger, grief, compassion, resilience and hope can be freely expressed, offering insights into the impact of ALS and helping to fuel hope for others facing this disease.”